Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
TENCENT Joins Stake in RNA Innovative Drugmaker MagicRNA: Report
Recommend 5 Positive 14 Negative 1 |
||||
|
||||
|
MagicRNA, a Chinese RNA innovative drugmaker, has recently added TENCENT (00700.HK)'s subsidiary, Guangxi Tencent Venture Capital, as one of its shareholders, Chinese media reported, citing data from Qichacha. The drugmaker's registered capital has increased to around RMB2.5574 million. Established in 2021, MagicRNA's business scope includes biomass technology services, medical research and experimental development, and cell technology research and application. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
